HomeACADEMIA
ACADEMIA

NCC to Begin IIT for Pediatric ALL with Velcade Plus 5 Drugs
(Feb.23.2017)

The National Cancer Center (NCC) said on February 22 that it will launch a PII investigator-initiated trial (IIT) on multi-drug remission-induction therapy for the treatment of acute lymphatic leukemia (ALL) in first-relapsed children. The program will be conducted at nine sites across Japan ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar